That a central immunological unresponsive state exists to our own body constituents is widely accepted. The precise role played by the various cell types of the lymphoid system in the maintenance or abrogation of this unresponsiveness to self remains unclear. A large number of nonself-antigens require the collaboration of thymus-derived (T) and bone marrow-derived (B) lymphocytes (1, 2). Although both T and B cells may be made unresponsive, only one cell type need be in order that the intact animal remain unresponsive (3). In a rabbit model, the cellular events in the termination of unresponsiveness to bovine serum albumin (BSA), 1 by the injection of cross-reacting albumins, were best explained by assuming that the T cells, but not the B cells, were unresponsive to BSA and to cross-reacting determinants on other albumins (4). Such a situation may explain the apparent ease with which unresponsiveness to self components may be abrogated in autoimmune disorders such as thyroiditis (5-7) and rheumatic fever (8).
ROLES OF T AND B CELLS IN MURINE THYROIDITIS
of soluble human, equine, and bovine Tg's daily for 6 days. A second and third series of injections were given with a 2-wk interval between series.
Isolation of Tgs.--Bovine and equine thyroids were obtained from local slaughterhouses, and murine thyroids were removed from normal female A/J mice. Human thyroids removed from autopsy specimens were kindly provided by Dr. Robert Nakamura, University of California at Irvine. The thyroids were minced and extracted in the cold with normal saline. Cell and tissue debris were removed by centrifugation in the cold at 10,000g for 30 min. The supernatant material was precipitated in the cold with ammonium sulfate as described by Rose and Stylos (9) . The Tg-rich fraction (1.7 M) was redissolved in phosphate-buffered saline (PBS), pH 7.2, and chromatographed on a 2.5 X 90 cm Sephadex G-200 column (Pharmacia Fine Chemicals, Inc., Piseataway, N. J.). The excluded peak was isolated and shown to contain approximately 90-95% Tg and some 5-10% serum proteins by immunoelectrophoresis (IEP). Small samples of each Tg were further purified by DEAE-cellulose chromatography as described previously and were found to be free of serum protein by IEP. The DEAE-purified Tg's were used in autoradiographic and antigen-binding capacity assays.
Detection of Plaque-Forming Cells (PFC) to Heterologous
Tg.--Heterologous Tg was covalently coupled to goat erythrocytes essentially as described previously (10) . The plaque assay was a modification (ll) of the method of Jerne to assay for direct PFC (D-PFC) (12) . For detection of indirect PFC (I-PFC), a goat antimouse IgG antiserum was appropriately diluted in a complement source of guinea pig serum. Appropriate controls were included in each plaque assay to determine the background to the target erythrocyte.
Histology.--Thyroids were removed from exsanguinated mice and placed in Bouin's solution for 8-24 h. The hematoxylin-eosin and periodic acidic-Sehiff sections were examined and graded for increased cellularity. Sections were scored from 0 to 4+. A normal thyroid was given a 0 score. A score of 1+ was given when there was interstitial accumulation of inflammatory cells distributed between two or more follicles. Where there were one to two loci of inflammatory cells equivalent in size to a folficle, a rating of 2-[-was given. A 3+ score indicated that about 10-40% of the thyroid was replaced by inflammatory cells and a score of 4+ indicated that greater than 40% was replaced by inflammatory cells.
lodination of Tg.--DEAE chromatographically purified Tg's were iodinated as described by McConahey and Dixon (13) ; for the autoradiographic and antigen-suicide studies, the specific activities ranged from 33-85 and 280-330 ~Ci//zg protein, respectively. For quantitative determinations of serum antibody to Tg by the antigen-binding capacity assay, the Tg's were labeled to a specific activity of approximately 0.1-0.5/zCi/~g protein.
Nitrogen Determinations.--Protein nitrogen determinations were performed by a modification of the micro-Kjeldahl technique using the Techuicon autoanalyzer (Teehnicon Instrument Corp., Tarrytown, N. Y.) (14) .
Autoradiographic Assay of Antigen-Binding Lymphocytes (ABL).--The autoradiographic
method was similar to that described by Davie and Paul (15) . Briefly, thymuses and spleens were removed from the mice after exsanguination and single-cell suspensions from each organ were made in minimal essential medium (MEM) or RPMI-1640 (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 10% fetal ealf serum (FCS) and 0.1% sodium azide. To 200/zl of medium containing 20 X l0 s nucleated cells was added 100 or 500 ng of [12SI]Tg; the cell suspensions were held at 4°C for 30 min. To remove unbound [12~I]Tg from the cell suspensions, each eell preparation was layered over 7 ml of FCS and eentrifuged at 200g. This step was repeated three times.
Cell smears were made on precleaned slides, air-dried, fixed, and emulsed in NTB-2 (Eastman Kodak Co., Rochester, N. Y.). Exposure times varied from 14-21 days; however, in one instance the exposure time was 90 days. The slides were developed and stained with Giemsa, and in each preparation, 10-200 >( 103 cells were scanned for the presence of grains. A positive cell had to fulfill the following criteria: (a) the cell had to be morphologically a lymphocyte; (b) there could be no discernible damage to the membrane or to other structures; (c) the cell could not touch other ceils or cellular debris; (d) the cell had to have at least a 20-fold increase above background (~-d grain/cell) grains on its surface or distributed about its circumference.
In blocking experiments with unlabeled Tg, the cell suspensions were mixed with a 750-15,000-fold excess of unlabeled Tg diluted in MEM and the mixture incubated at 4°C for 2 h. Then, the cell suspensions were washed twice with fresh MEM before incubation with [125I]-Tg under standard conditions. In blocking experiments with antisera, the cell suspensions (200/Zl) were incubated with equal volumes of appropriately diluted antisera for 2 h at 4°C and washed twice in fresh MEM before the addition of [12~I]Tg.
Antisera.--Before use, all antisera were heated at 56°C for 30 min and absorbed with A/J thymocytes (108 cells/ml of antiserum) in order to remove heterophile antibodies to murine cells. Normal goat and rabbit sera were obtained from animals before immunization in order to assess the background inhibitory capacity of each serum. The antimouse Fab antiserum was prepared by repeated injections of a goat with Fab fragments from papain-digested normal mouse IgG. This antisera detected K, X, and Fd determinants as ascertained by Ouchterlony analysis. A rabbit antimouse/z-chain serum was prepared by repeatedly injecting rabbits with purified MOPC-104 E IgM myeloma protein. To render the antisera/z-chain specific, it was absorbed with neonatal mouse serum, MOPC-46 K-chains, h-chains of 104 E, and Fab fragments of PC-5 myeloma. The anti-IgG heavy-chain specific antiserum was prepared in rabbits by repeated injections of mouse IgG in Freund's complete adjuvant and was absorbed for "),-chain specificity with Fab fragments of PC-5 myeloma, MOPC-46 K-chain, MOPC-315 IgA myeloma, and MOPC-104 E IgM myeloma proteins. All the antiheavy-chain antisera and the anti-Fab antiserum were tested by indirect immunofluorescence and direct immunofluorescence, respectively, on ethanol-fixed mouse myeloma cells ($121, W33, MOPC 315, MOPC 104E, PC-5, and 183). These studies permitted both the determination of the specificity and the relative potency of each antiserum. By this test, all the antisera were judged to be specific and to give positive fluorescence at a dilution of greater than 1:40. The tubes were mixed and incubated at 37°C for 1 h and overnight at 4°C; then, an appropriate quantity of goat antimouse Fab (IgG) antiserum was added to each tube in order to precipitate the mouse immunoglobulins (Ig). The mixture was incubated at 37°C for 60 min and then at 0°C for 00 min, at which time a heavy precipitate formed. The precipitate was pelleted by centrifugation (in the cold) at 1000g for 20 min and the supernate removed. The pellet was resuspended in 2 ml of cold PBS, pH 7.2, and the centrifugation process repeated. The final supernate was removed and the precipitate counted in a two channel, well-type gamma counter. For each dilution of antisera, the percentages of Tg and of mouse Ig precipitated were calculated. A plot of the log dilution of the antiserum versus the percent Tg remaining in the supernate produced a sigrncid curve. The dilution at which 33% of the Tg was bound was determined from the semilogarithmic graph. This number allowed the calculation of the ABC value for each antiserum. Normal mouse serum served as a background control for each experiment in which less than 2% of the Tg added was bound. Between 85-100% of the mouse Ig in each antiserum dilution was precipitated by 200 #1 of goat antimouse Fab antiserum. To determine the degree to which heterologous Tg would competitively inhibit the binding of [lalI]mousc Tg by selected antisera, the ABC assay was modified slightly. 5 #l-aliquots of concentrated (40 mg protein/ml) individual heterologous Tg's were added to serial dilutions of antisera and the mixture incubated for 1 h at room temperature. Then the [131I]mousc Tg was added and the standard procedure was followed as described above. As a control for dilution effect, 5/~1 of FCS was added in place of heterologous Tg. Additionally, pooled immune mouse antisera were absorbed at equivalence with an equal mixture of soluble equine, human, and bovine Tg, until no further precipitation was observed, at which time 4 mg or 40 mg of an equal mixture of bovine and equine Tg were added to insure completeness of absorption. As in the above experiment, an aliquot of the antisera had a volume of either PBS or FCS added, which was equivalent to that of the added Tg. All the antisera were tested for the capacity to bind either iodinated mouse or iodinated bovine Tg, as described previously.
Quantitation of Antibody to Mouse
t~ Antigenic Suicide of Normal Bone Marrow and Thymus.--Syngeneic mouse Tg was iodinated with 125I at a specific activity of 280-330 #Ci//zg protein as described previously (13) . Normal thymocytes and bone marrow were collected from 6-8-wk old A/J female mice. The cells were suspended in MEM with 10% FCS at 5 × 10 ~ cells/ml and were incubated separately with [l~SI]murine Tg at a ratio of approximately 3 #g/10 s ceils. The cell suspensions were held at 4°C for 5 h. Then, the cells (5 ml) were layered over 20 ml FCS and centrifuged at 200g for 15 rain in the cold and the process was repeated twice. Mter the final wash, the treated cells together with untreated lymphocytes from the other cooperating cell line were suspended in MEM and injected intravenously into lethally (900 R) irradiated, thymectomized (Tx) recipients. 4--6 days after reconstitution, the animals were immunized according to the standard regimen of heterologous Tg's. In one experiment, additional mice in each group were sacrificed at a later time (day 52) to determine the incidence and extent of thyroid lesions. Table I , a PFC response to bovine, equine, and human Tg's was observed in the spleens of mice injected with an equal mixture of human, bovine, and equine Tg. The responses to bovine and equine Tg were similar, whereas the response to human Tg was lower than that observed with either bovine or equine. This was a consistent finding during these studies, and for this reason, in all subsequent PFC assays, bovine Tg was selected as the antigen of choice for the PFC assay. Although not shown in Table I , D-PFC were observed only during the first 5 days after the cessation of the first series of daily Tg injections. The D-PFC response was usually 500-3,000 PFC/spleen. However, after the second and third series of Tg injections, the plaque response was almost exclusively of the I-PFC type. amount of Tg required during the conjugation of antigen to erythrocytes and in consideration of the limited amount of murine Tg available, no attempt could be made to directly assay for PFC to murine Tg. Rather, a modification of the ABC was employed to measure antibody reacting with murine Tg. The data in Fig. 1 show that only after the second and third series of Tg injections do appreciable amounts of antibody reacting with syngeneic Tg appear in the serum. The dramatic drop (88 %) in the serum antibody levels at days 40-45, at a time when heterologous Tg is injected, correlates well with inhibition of 1200-
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, , ~ the ABC. The in vivo absorption of serum antibody suggests that most of the antibody produced which reacts with murine Tg, also cross-reacts with the hetero'.ogous Tg's. Furthermore, the appearance of PFC to bovine Tg precedes by 3-5 days the subsequent elevation of antibody in the sera to murine Tg. As antibody reappears in the circulation (day 48) and reaches a maximum (day 50) value, the incidence of thyroid lesions is low; however, thereafter (days 51-55) the incidence of lesions reaches a maximum of approximately 90 % and the antibody to murine Tg declines.
ttistology.--A representative lesion at day 52 is shown in Fig. 2 where the noteworthy histopathological features of the inflammatory loci are the prevalence of neutrophiles, dissolution of colloid material, and disruption of follicular integrity. A minor mononuclear inflammatory cell reaction was also observed. The mononuclear inflammatory reaction became the prominent histological feature from day 54 through 75.
Specificity of Serum Antibody.--As previously indicated, the serum of mice immunized with a mixture of heterologous Tg's appeared to contain, in large part, antibodies cross-reacting to common determinants shared by all three of the heterologous Tg's. The administration of cross-reactive heterologous Tg's allows collaboration of T and B cells because the noncross-reactive determinants on the heterologous Tg's stimulate a specific population of T cells. At the same time, antigen-reactive B cells react with both cross-reactive determinants and heterologous-specific determinants and as such, both crossreactive antibody and heterotogous-specific antibody are produced. Thus, the specificity of antibody appearing in the serum reflects the cellular status of the host. In this respect, these experiments were designed to investigate the degree of cross-reactivity of antibody and whether any antimurine Tg-specific antibody was produced. The data in Table II demonstrate that bovine, equine, and human Tg, added individually at saturating levels, produced almost identical inhibition (73-76 %) of the ABC to mouse Tg. As the level of soluble inhibitor decreased, the degree of inhibition declined correspondingly. As a control for dilution and specificity, an excess of non-Tg proteins and FCS was added to an aliquot of pooled immune serum. The FCS produced no detectable inhibition of the ABC value. An additional aliquot of the antiserum was absorbed at equivalence with an equal mixture of equine, bovine and human Tg's, and an excess unlabeled Tg (4 mg or 40 mg) added to insure completeness of absorption. This absorbed antiserum contained no antibodies capable of binding iodinated bovine Tg, but retained a small but significant population of antibodies specific for murine Tg when a mixture of 4 mg of the excess unlabeled Tg's were added. At 40 mg excess of bovine and equine Tg, no antibody to murine Tg remained. An aliquot of appropriately diluted unabsorbed antiserum served as a control to which the absorbed antiserum was compared. These data show that all the antibody produced that reacts with murlne Tg also cross-reacts with the heterologous antigens. Table III , lethally irradiated and Tx mice reconstituted with normal bone marrow, and injected with heterologous Tg's did not produce antibody (PFC) and did not have discernible lesions. Conversely, lethally irradiated Tx mice reconstituted with normal bone marrow or "B" spleen cells and normal thymocytes were able to generate both I-PFC and thyroid lesions, after heterologous Tg injections. Similarly, recipients of normal spleen cells produced PFC and lesions. By the nature of the experimental protocol, the possibility that recipients reconstituted with only thymocytes could produce lesions was untestable, since such mice died from hematopoietic stem cell failure 7-10 days postirradiation. Thus, these T-cell reconstituted mice do not survive the 50-60 days normally required for lesion production.
Thymus and Bone-Marrow Synergism in Production of Antibody and of Thyroid Lesions.--As shown in
Effect of Prior Exposure of B Cells to Tg as Measured by Synergistic
Response with T Cells.--The experiment described in Table IV 
TABLE IV
Effect of Prior Exposure of B Cells to Antigen as Measured by Synergistic Response with T Cells
No. of Tx, lethally irradiated* recipient anmice reconstituted with: imals (Table V) was observed with the three test anti. Table VIII clearly show that normal bone-marrow cells were susceptible to the lethal effects of heavily iodinated syngeneic Tg. In two experiments the degree of suppression of the I-PFC response to bovine Tg was 80 % and 88 %. Of great importance was the observation that 56 % of such animals had no thyroid lesions at a time (day 52) when 100 % of the animals reconstituted with normal thymocytes and bone marrow had lesions. Not only was the incidence diminished in the bone-marrow suicidal group, but the severity of the lesions was less than in the control group in which 85 % of the animals had moderate inflammatory involvement (grade 1-2+) as compared to 37% in the bone-marrow suicidal group. Equally as important was the finding in both experiments that normal thymocytes were not severely affected by heavily iodinated syngeneic Tg, since their responses to heterologous Tg were similar in magnitude to control values. The incidence of lesions in this group was 90 %; of those animals having lesions, 75 % had moderate inflammatory involvement.
DISCUSSION
The data presented in this paper have demonstrated the cellular requirements for murine autoimmune thyroiditis induced by immunization with heterologous Tg's. The production of autoantibody to murine Tg and the induction of lesions required the presence of both specific T and B cells. Animals that were Tx, irradiated, reconstituted with normal bone marrow, and injected with a mixture of soluble heterologous Tg's did not produce any D-PFC or I-PFC to heterologous Tg. These same animals showed no histological evidence of thyroiditis. By contrast, mice that were Tx, irradiated, reconstituted with normal thyrnocytes and bone marrow or spleen cells were able to produce both D-PFC and I-PFC and thyroid lesions.
Secondly, the absence of significant numbers of [a25I]syngeneic Tg ABL in the thymus of normal mice would be compatible with the hypothesis that un-responsiveness to some self-antigens resides exclusively in the thymus. However, the hypothesis also assumes that the B-cell compartment is immunocompetent and as such may recognize cross-reacting and self-antigens ([1251] syngeneic Tg). Further, the T-cell pool must be capable of recognizing crossreacting Tg's via noncross-reacting determinants. The ABL data fully support this hypothesis. No significant number of thymic ABL reacting with [mI] syngeneic Tg were demonstrable while under similar conditions, significant numbers (30/105 lymphocytes) of ABL were demonstrable for the cross-reacting heterologous Tg's. Normal A/J spleen cell preparations contained comparable quantities of ABL for syngeneic and the two heterologous Tg's tested (human and bovine). As expected, an excess of cold syngeneic or heterologous Tg inhibited the binding of [mI]syngeneic Tg. In general, the inhibition data are in agreement with those reported by Byrt and Ada (17) who found that pretreatment of normal spleen cells with a 10,000-fold excess of noniodinated flagellin reduced substantially the numbers of flagellin ABL.
In the homozygous athymic nude mouse, comparable numbers of ABL were observed with [~SI] human Tg and with [l~SI]murine Tg. The cells binding the iodinated antigens in the spleens of these athymic mice are primarily, if not exclusively, B-derived cells (18) . This type of experimental approach does not constitute formal proof that the ABL's found with [~SI] syngeneic Tg in an intact normal mouse are exclusively B lymphocytes although by inference it must be considered strong supportive evidence for it. Further evidence implicating B cells as the ABL for self-antigens may be found in a recent report of Bankhurst et al. (19) . They demonstrated that peripheral blood lymphocytes from normal human patients subjected to double-layer antihuman Ig-coated bead column which removes lymphocytes bearing large amounts of surface Ig, effectively abolished or drastically reduced the number of autoradiographic positive cells to [~2~I]homologous Tg.
Along these same lines, there was an increase in the number of ABL for both syngeneic Tg and heterologous Tg's when mice were immunized with only human Tg 8 mo before sacrifice. The lymphocytes binding [t2~I]syngeneic Tg were most probably a pure B population; however, the source of those cells binding the [~I] heterologous Tg may well have been mixture of B and T cells. Ample evidence exists for the presence of T cells functioning as ABL (20) (21) (22) . Whether the ABL which reacted with [125I]syngeneic Tg are B memory cells or precursors of PFC and whether the immunoglobulin surface receptors on these cells are lz-or ~'-chains remains to be investigated.
Thirdly, radioactively labeled syngeneic Tg incubated with normal bonemarrow cells under conditions favoring radiation damage abrogated the capacity of these cells to collaborate with normal thymocytes when adoptively transferred to a Tx-irradiated host. Upon challenge with cross-reacting Tg's, such animals exhibited a markedly decreased antibody response (I-PFC) and subsequently had a decreased incidence of thyroid lesions. When normal thymocytes were incubated with [!25I]syngeneic Tg and injected with normal bone-marrow cells into a Tx-irradiated host, a response comparable to that of the control group was observed upon challenge with the cross-reacting Tg's. This experiment established directly the fact that the B-cell pool in normal mice recognizes the self-antigens and therefore is immunocompetent while the T-cell pool does not recognize self-antigens and therefore may be considered unresponsive.
The problem of antigen suicide of normal bone marrow versus suicide of normal B-derived lymphocytes is still a matter of controversy. Unanue (23) was able to demonstrate antigen suicide of normal bone marrow with heavily iodinated KLH; on the other hand, Basten et al. (24) were unable to suicide bone-marrow cells but did suicide B-derived cells. Yet it is clear from the work of Chiller et al. (3) that bone marrow does contain antigen-sensitive cells since they are capable of being rendered unresponsive with deaggregated human gamma globulin. This type of data suggests that normal bone marrow does contain antigen-specific immunocompetent cells. One reason why Unanue (23) and we were able to suicide normal bone marrow may be that substantially larger amounts and more intensely iodinated antigen were employed.
The interrelationship between thyroid lesions and antibody was dramatically clarified with the suicide of normal bone marrow. When antibody is decreased dramatically, the incidence and severity of lesions decreased. Further support for the role of antibody may be ascertained from the temporal relationship between the elevation (day 48-50) of serum antibody reacting with mouse Tg and the subsequent appearance of inflammatory cells in the thyroid on day 52. The histopathological nature of these lesions was in part neutrophilic in character; this type of lesion has often been associated with acute inflammatory reactions mediated by antigen, antibody, and the complement system (25, 26) . Clinton and Weigle (10) reported that rabbits immunized with soluble bovine Tg exhibited a similar kinetic interrelationship between the appearance of splenic PFC and serum antibody to Tg. In their rabbit model, they found that coincidental with the appearance of thyroid lesions, I-PFC to rabbit Tg reached a peak in the thyroid. As they suggested, the thyroid may act as a specific immunoabsorbent for circulating B memory cells and as such, an accumulation of sensitized lymphocytes specific for rabbit Tg would be expected in the thyroid at this time. That specific antibody to Tg passively transfers thyroiditis has been dearly demonstrated for rabbits (27) and mice (28) . On the other hand, the degree of thyroiditis in guinea pigs has been correlated best with the level of cellular immunity to Tg (29~ 30).
The immunoglobulin receptor on spleen cells that binds [125I]syngeneic Tg was composed of/z-chains and light chains, since antisera specific for mouse /z-chain and for mouse ~, X, and Fd (IgG) determinants significantly blocked the binding of [~SI]syngeneic Tg. The binding site did not appear to be influenced by anti-IgG-specific antisera. It has been reported that both anfi-/~ and -3, (20) or only anti-# (31-33) heavy-chain serum significantly inhibit the binding of iodinated antigens in normal spleen cell populations. Perhaps, in the immunocompetent B-cell pool, the receptors on cells specific for selfantigens are class restricted to #-chains only.
SUMMARY
The data presented in this paper support the hypothesis that unresponsiveness to autologous thyroglobulin (Tg) exists in the T cells and responsiveness exists in the B cells. Such a conclusion is based on the results of antigenbinding studies where few, if any, thymocytes recognized syngeneic Tg. Comparable numbers of antigen-binding lymphocytes for syngeneic Tg were found in the spleens of normal intact mice and of nude mice. The latter fact suggested that B cells exist which recognize self-constituents. From antigensuicide experiments, a clearer picture of the susceptibility of B cells to iodinated self-antigen and of the obligatory role of antibody in the induction of lesions was developed. Only bone marrow cells (B cells) were affected by [nq]syngeneic Tg, in which case the incidence of lesions was diminished. From adoptive transfer experiments, the results demonstrate that unresponsiveness may be terminated by immunization with a mixture of heterologous (crossreacting) Tg's. In this situation T cells are required since a B-cell reconstituted host failed to make antibody (plaque-forming cells) and to develop lesions. T cells in this form of an unresponsive state may recognize determinants on the heterologous Tg unrelated to autologous Tg and as such stimulate the normal complement of B cells to produce antibody that both reacts with autologous and heterologous Tg.
